Cape Investment Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Cape Investment Advisory's LLY Position: Q2 2026 in Review
Cape Investment Advisory increased its Eli Lilly (LLY) stake by 9.2% in Q2 2026, buying an estimated $39.8K and bringing the position to 464 shares worth $557K. The position accounts for 0.15% of the portfolio, ranked #117.
Cape Investment Advisory first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,583 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cape Investment Advisory held 464 shares of Eli Lilly worth $557K as of Q2 2026.
- Cape Investment Advisory bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
- Eli Lilly made up 0.15% of Cape Investment Advisory's portfolio in Q2 2026, its #117 holding.
- Cape Investment Advisory first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
- 1,583 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.